![Feng Ren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Feng Ren
Directeur Général chez
INSILICO MEDICINE CAYMAN TOPCO
Fortune : 7 M $ au 31/08/2026
Profil
Feng Ren is currently Co-Chief Executive Officer & Executive Director at InSilico Medicine Cayman TopCo since 2023 and Co-CEO, Director & Chief Scientific Officer at InSilico Medicine, Inc. Formerly, Dr. Ren was Director & Head-Chemistry at GSK Plc from 2007 to 2018 and Senior Vice President & Head-Chemistry & Biology at Shanghai Medicilon, Inc. from 2018 to 2021.
Education includes a doctorate from Harvard University in 2007, a graduate degree from National University of Singapore in 2004, and an undergraduate degree from the University of Science & Technology of China in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/07/2026 | 1 288 055 ( 0,22 % ) | 7 M $ | 31/08/2026 |
Postes actifs de Feng Ren
| Sociétés | Poste | Début |
|---|---|---|
| INSILICO MEDICINE CAYMAN TOPCO | Directeur Général | 01/06/2022 |
InSilico Medicine, Inc.
 InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Directeur Général | - |
Anciens postes connus de Feng Ren
| Sociétés | Poste | Fin |
|---|---|---|
| SHANGHAI MEDICILON INC. | Corporate Officer/Principal | 01/01/2021 |
| GSK PLC | Directeur/Membre du Conseil | 01/01/2018 |
Formation de Feng Ren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National University of Singapore
 National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
 University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Medicilon, Inc.
 Shanghai Medicilon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and develop biotechnology drug discovery contract research organization | Commercial Services |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Technology Services |
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Pharmaceuticals: MajorHealth Technology Develops therapeutic pipeline technology and AI software platform | Health Technology |
